Applicants must submit: (1) requests for revision of the regulatory review period under 21 CFR 60.25; (2) due diligence petitions under 21 CFR 60.30; and requests for hearings under 21 CFR 60.40 regarding decisions on the petitions.
US Code:
35 USC 156
Name of Law: Generic Animal Drug and Patent Term Restoration Act of 1988
US Code:
21 USC 355(j)
Name of Law: Drug Price Competition and Patent Term Restoration Act of 1984
Originally, the ICR submitted three years ago was submitted and/or lumped together as 1 IC, but, in reality there are 3 ICs. The submission of this ICR package will show in Part 2 each IC, and so the number of submissions and respondents under this information collection remains the same.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.